Literature DB >> 20833657

Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles.

Fumiaki Tanaka1, Ken Yamamoto, Sadao Suzuki, Hiroshi Inoue, Masahiko Tsurumaru, Yoshiaki Kajiyama, Hoichi Kato, Hiroyasu Igaki, Koh Furuta, Hiromasa Fujita, Toshiaki Tanaka, Yoichi Tanaka, Yoshiyuki Kawashima, Shoji Natsugoe, Tetsuro Setoyama, Shinkan Tokudome, Koshi Mimori, Naotsugu Haraguchi, Hideshi Ishii, Masaki Mori.   

Abstract

BACKGROUND: Oesophageal squamous cell carcinoma (OSCC) is considered a difficult cancer to cure. The detection of environmental and genetic factors is important for prevention on an individual basis.
OBJECTIVE: To identify groups at high risk for OSCC by simultaneously analysing both genetic and environmental risk factors. Methods A multistage genome-wide association study of OSCC in Japanese individuals with a total of 1071 cases and 2762 controls was performed.
RESULTS: Two associated single-nucleotide polymorphisms (SNPs), as well as smoking and alcohol consumption, were evaluated as genetic and environmental risk factors, respectively, and their interactions were also evaluated. Risk alleles of rs1229984 (ADH1B) and rs671 (ALDH2) were highly associated with OSCC (odds ratio (OR)=4.08, p=4.4×10(-40) and OR=4.13, p=8.4×10(-76), respectively). Also, smoking and alcohol consumption were identified as risk factors for OSCC development. By integrating both genetic and environmental risk factors, it was shown that the combination of rs1229984 and rs671 risk alleles with smoking and alcohol consumption was associated with OSCC. Compared with subjects with no more than one environmental or genetic risk factor, the OR reached 146.4 (95% CI 50.5 to 424.5) when both environmental and genetic risk factors were present. Without the genetic risks, alcohol consumption did not correlate with OSCC. In people with one or two genetic risk factors, the combination of alcohol consumption and smoking increased OSCC risk.
CONCLUSIONS: Analysis of ADH1B and ALDH2 variants is valuable for secondary prevention of OSCC in high-risk patients who smoke and drink alcohol. In this study, SNP genotyping demonstrated that the ADH1B and/or ALDH2 risk alleles had an interaction with smoking and, especially, alcohol consumption. These findings, if replicated in other groups, could demonstrate new pathophysiological pathways for the development of OSCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20833657     DOI: 10.1136/gut.2009.205724

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  58 in total

1.  Genetic variations in MTHFR and esophageal squamous cell carcinoma susceptibility in Chinese Han population.

Authors:  Weifeng Tang; Sheng Zhang; Hao Qiu; Lixin Wang; Bin Sun; Jun Yin; Haiyong Gu
Journal:  Med Oncol       Date:  2014-04-01       Impact factor: 3.064

2.  p53 immunohistochemical expression and patient prognosis in esophageal squamous cell carcinoma.

Authors:  Asuka Murata; Yoshifumi Baba; Masayuki Watanabe; Hironobu Shigaki; Keisuke Miyake; Ryuichi Karashima; Yu Imamura; Satoshi Ida; Takatsugu Ishimoto; Shiro Iwagami; Yasuo Sakamoto; Yuji Miyamoto; Naoya Yoshida; Hideo Baba
Journal:  Med Oncol       Date:  2013-09-13       Impact factor: 3.064

3.  A variant allele of ADH1B and ALDH2, is associated with the risk of esophageal cancer.

Authors:  Haiyong Gu; Dingxu Gong; Guowen Ding; Wenbo Zhang; Chao Liu; Pengcheng Jiang; Suocheng Chen; Yijang Chen
Journal:  Exp Ther Med       Date:  2012-04-17       Impact factor: 2.447

4.  CYP1A1 and CYP2E1 genotypes and risk of esophageal squamous cell carcinoma in a high-incidence region, Kashmir.

Authors:  Gulzar Ahmad Bhat; Idrees Ayoub Shah; Muzamil Ashraf Makhdoomi; Beenish Iqbal; Rumaisa Rafiq; Sumaiya Nabi; Akbar Masood; Mohd Maqbool Lone; Nazir Ahmad Dar
Journal:  Tumour Biol       Date:  2014-02-08

5.  Risk assessment of metachronous squamous cell carcinoma after endoscopic resection for esophageal carcinoma based on the genetic polymorphisms of alcoholdehydrogense-1B aldehyde dehydrogenase-2: temperance reduces the risk.

Authors:  Satoshi Abiko; Yuichi Shimizu; Shuichi Miyamoto; Marin Ishikawa; Kana Matsuda; Momoko Tsuda; Takeshi Mizushima; Keiko Yamamoto; Shoko Ono; Takahiko Kudo; Kota Ono; Naoya Sakamoto
Journal:  J Gastroenterol       Date:  2018-02-08       Impact factor: 7.527

Review 6.  Molecular mechanisms of ethanol-associated oro-esophageal squamous cell carcinoma.

Authors:  Yao Liu; Hao Chen; Zheng Sun; Xiaoxin Chen
Journal:  Cancer Lett       Date:  2015-03-09       Impact factor: 8.679

7.  Alcohol and acetaldehyde in African fermented milk mursik--a possible etiologic factor for high incidence of esophageal cancer in western Kenya.

Authors:  Mikko T Nieminen; Lily Novak-Frazer; Rebecca Collins; Sonja P Dawsey; Sanford M Dawsey; Christian C Abnet; Russell E White; Neal D Freedman; Michael Mwachiro; Paul Bowyer; Mikko Salaspuro; Riina Rautemaa
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-11-15       Impact factor: 4.254

8.  Esophageal squamous cell cancer in a highly endemic region.

Authors:  Akwi W Asombang; Violet Kayamba; Mpala M Lisulo; Kathryn Trinkaus; Victor Mudenda; Edford Sinkala; Stayner Mwanamakondo; Themba Banda; Rose Soko; Paul Kelly
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

9.  Clinical significance of mediastinoscope-assisted transhiatal esophagectomy in patients with esophageal cancer.

Authors:  Hiroshi Okumura; Yasuto Uchikado; Masataka Matsumoto; Itaru Omoto; Ken Sasaki; Yoshiaki Kita; Takaaki Arigami; Yoshikazu Uenosono; Akihiro Nakajo; Tetsuhiro Owaki; Shinichiro Mori; Sumiya Ishigami; Shoji Natsugoe
Journal:  Langenbecks Arch Surg       Date:  2015-08-08       Impact factor: 3.445

Review 10.  Surveillance for gastrointestinal malignancies.

Authors:  Ashish K Tiwari; Heather S Laird-Fick; Ramesh K Wali; Hemant K Roy
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.